Mideast Stocks: Emiartes NBD lifts Dubai; Saudis extend losses
In Saudi Arabia, the index was down 0.3%. Al Rajhi Bank shed 0.7% and Alinma Bank dropped 1.5%
Reuters News - 28 Oct 2019
Al Hammadi Company for Development and Investment (4007.SE)
Also known as: Al Hammadi
27.80 SAR 0.000.00%
Al Hammadi Stock Price & Performance
Recommendation
-
Div Yield
-
P/E (Last 12 Month)
34.68
Upside
-
Target Price (Mean)
-
Open
Data not available
Previous Close
27.80 SAR
Turnover
Data not available
EPS
0.781 SAR
Volume
0
Transactions
0
Market Cap
3.34B SAR
IPO Date
14-Jul-2014
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Al Hammadi Company for Development and Investment
Business Summary
Ownership, operation and management of general hospitals; distribution of medical equipment, medical supplies and pharmaceuticals.
Country of Incorporation
Ownership Type
Established In
1985
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| 4007.SSE | Ordinary | SAR | Saudi SE | 4007 |
Contact details
Primary address
Al Hammadi Hospital - Al Olaya BuildingAl Oruba Street
Al Olaya District
55004
Saudi Arabia
Riyadh
11534
CONTACT
- Tel: +966 11-232-9999
- Fax: +966 11-231-9999
- Email: alhammadi.com
Region
RiyadhOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Mr Mohammed Saleh Mohammed Al Hammadi
Chief Executive Officer and Managing Director
Mr Mohammed Said Suleiman Al Saafeen
Chief Financial Officer
Dr Abdulaziz Saleh Mohammed Hamad Al Hammadi
Chief Operating Officer
Board Members
Mr Saleh Mohammed Hamad Al Hammadi
Chairman
Dr Abdulaziz Mohammed Hamad Al Hammadi
Vice Chairman
Dr Sami Abdullah Dakheilallah Al Said
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
